Known global pharmaceutical company Astra Zeneca invited select media from various platforms as brought up some relevant on anything about Type 2 Diabetes.
According to their study, 1 out of 10 Filipinos have Type 2 Diabetes (T2DM). The difference of it versus Type 1 Diabetes are characterized by insufficient insulin production and/or inability to respond its effects.
Dr. Roberto Mirasol gave us on the T2DM on a global scale. So far, Asians are more prone to this medical problem compared to Caucasians mainly of the carbo-based diet. Inactivity was another main cause.
Dr. Rima Lim explained more on the effects of T2DM. She also explained the benefits of Astra Zeneca's revolutionary product Dapaggliflozin which was approved by the FDA last Feburary 2014 and recognized by 40 countries globally. The product can be taken once daily with the patient's regular ant-diabetes drugs. It is highly selective and reversible inhibitor or sodium-glucose co-transporter 2 (SGLT2) that works independently of insulin to hep remove excess glucose from the body The product prevents glucose from re-entering the circulation, causing it to be released thru urine. In their tests, it can release 70 grams of glucose per day.
It is now available thru Mercury Drug for Php 61.50 but like all of medical experts said, you have to consult for doctor before taking it.
Dr. Roberto Mirasol, FDCP, FPSEM is the President of Phil. Association for the Study of Obesity and Overweight (PASOO) and previous President of the Phil. Society of Endocrinology, Diabetes & Metabolism (PSEDM) and ASEAN Federation of Endrocrine Societies (AFES). He is the Chief of the Section of Endocrinology, Diabetes & Metabolism and the previous Head of the Weight Management Center of St. Lukes Medical Center, QC. He is also the section chef of the section of endocrionology of the Manila Doctors Hospital as well as the head of the Diabetes Clinic and Thyroid Clinic at Rizal Medical Center.
Dr. Rima Tan currently sits as the President for Diabetes Philippines, as well as Treasurer for the Institute for Studies on Diabetes Foundation Inc., where she also sits as a faculty member. She also works as a consultant for Capitol Medical Center and FEU-NRMF Medical Center.
